Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder

Journal of Clinical Psychopharmacology

Volumn 29, Issue 5, 2009, Pages 503-504

  Shepherd, Jonathan ^a   Garza, Víctor M ^a   De León, Ovidio A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BROMOCRIPTINE; CLONAZEPAM; INFUSION FLUID; LORAZEPAM; OXCARBAZEPINE; RISPERIDONE; SERTRALINE; TOPIRAMATE;

ADULT; AUTISM; BIPOLAR DISORDER; CASE REPORT; CATATONIA; COMMUNICATION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; LETTER; MAJOR DEPRESSION; MALE; MANIA; MENTAL DEFICIENCY; NEUROLEPTIC MALIGNANT SYNDROME; NURSING HOME; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; TREMOR; WEIGHT GAIN;

ADULT; AUTISTIC DISORDER; BIPOLAR DISORDER; CATATONIA; HUMANS; MALE; PIPERAZINES; QUINOLONES;

EID: 70349693628     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181b5494b     Document Type: Letter

References (14)

1. Woddbury MM, Woodbury MA. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry. 1992;31:1161-1164.
2. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000;176:357-362.
3. Bush G, Fink M, Petrides G, et al. Catatonia: I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:137-143.
4. Sachdev PS. A rating scale for neuroleptic malignant syndrome. Psychiatry Res. 2005;135:249-256.
5. Varkula M, Dale R. Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man. J Clin Psychopharmacol. 2008;28:245-247.
6. White AC. Catatonia and neuroleptic malignant syndromeVa single entity? Br J Psychiatry. 1992;161:558-560.
7. Lee JWY. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Ann Clin Psychiatry. 2007;19:9-16.
8. Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transmission. 2002;109:1453-1467.
9. Dosssche DM, Shah A, Wing L. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. Int Rev Neurobiol. 2006;72:267-284.
10. Fink M, Taylor MA. Catatonia. Cambridge, UK: Cambridge University Press; 2003.
11. Adityanjee A, Mathews T, Aderibigbe YA. Proposed research diagnostic criteria for neuroleptic malignant syndrome. Int J Neuropsychopharmacol 1999;2:129-144.
12. Kakooza-Mwesige A, Wachtel LE, Dhossche DM. Catatonia in autism: implications across the life span. Eur Child Adolesc Psychiatry. 2008;17:327-335.
13. Lausberg H, Hellweg R. Katatones dilemma. Therapie mit lorazepam und clozapin. Der Nervenarzt. 1998;69:818-822
14. Bachevalier J, Loveland KA. The orbitofrontal-amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci Biobehav Rev. 2006; 30:97-117.